Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyFlorida Blue Responsible Quantity Limits Policy Up…
    Ask Trek AI about this page
    CurrentFlorida BluePolicy N/A

    Responsible Quantity Program — Drug Dispensing Quantity Limits

    Customize your policy alerts

    Sign up for all Florida Blue policy alerts

    Know when Florida Blue releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines monthly (or other interval) dispensing quantity limits for numerous prescription drugs under Florida Blue's Responsible Quantity Program; applies to providers and pharmacies submitting claims and to generic versions where applicable.

    Policy Summary
    PayerFlorida Blue
    PolicyResponsible Quantity Program — Drug Dispensing Quantity Limits
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJul 1, 2026
    Next Review DateN/A
    Key ActionUse the Quantity Limit Authorization Form (linked) to request exceptions or overrides to listed dispensing limits.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    dozens+drugs listed with dispensing limits in this segment
    Q-Formauthorization form referenced
    applies to genericsapplies to generics where applicable
    7/1/2026current effective date

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Drug Dispensing Quantity Limits

    sample_drug_limits_from_document

    Per-drug dispensing limits (examples extracted from the list):

    Abacavir — Dispensing Limit Per Month: 60 tabs (all strengths if none listed).
    Abilify (aripiprazole) — Dispensing Limit Per Month: 30 tabs (all strengths if none listed).
    Abilify Discmelt (aripiprazole ODT) — Dispensing Limit Per Month: 60 tabs (all strengths if none listed).
    Actemra — Dispensing Limit Per Month: 4 syringes or autoinjectors / 28 days (162 mg syringe/auto-injector default).
    Afrezza — Dispensing Limit Per Month: up to 2520 cartridges per month (varies by strength).

    Dispensing limit entries

    Drug-specific default strengths and dispensing limits are listed; unless otherwise noted, the listed per-month (or per-period) quantities apply.

    Brixadi — Dispensing Limit Per Month: 4 syringes / 28 days (strengths noted in the list).
    Brukinsa — Dispensing Limit Per Month: 120 caps or 60 tabs depending on formulation (default strength/form noted where applicable).
    Buphenyl (sodium phenylbutyrate) — Dispensing Limit Per Month: 1200 tabs (tablet) or 600 grams (powder) as listed.
    Butorphanol tartrate nasal spray — Dispensing Limit Per Month: 2 bottles.
    Bydureon / Bydureon BCise — Dispensing Limit Per Month: 4 syringes / 28 days (or 4 auto-injectors / 28 days for BCise).

    Per-drug dispensing limits

    For each listed drug, the policy specifies a default strength/form (if none listed assume the indicated default) and a Dispensing Limit Per Month (or per specified days). Limits apply unless otherwise noted; exceptions may be handled via the Quantity Limit Authorization Form.

    Ditropan XL (oxybutynin ER) — 5 mg default; Dispensing Limit Per Month: 30 tabs.
    Dupixent — Dispensing Limit Per Month: 2 syringes OR pens / 28 days (maintenance starting Day 15 and beyond).
    Eliquis — multiple strengths/forms; Dispensing Limits vary by strength/form (examples: 74 caps / 30 days; 60 tabs; 5 boxes / 28 days for certain oral suspensions; 1 pack / 180 days for starter pack).
    Enbrel — Dispensing Limit Per Month: 8 vials / 28 days or 4 syringes / 28 days depending on presentation.
    Emtriva (emtricitabine) — Dispensing Limit Per Month: 30 caps or 680 mL depending on formulation.

    Sample dispensing limits

    Drug-specific dispensing limits (examples shown) — unless otherwise noted, limits apply per month or per the specified period.

    Glatopa (glatiramer acetate) 20 mg — 30 syringes per month; 40 mg — 12 syringes per 28 days.
    Gleevec (imatinib) 100 mg — 90 tabs per month; 400 mg — 60 tabs per month.
    Glucose Test Strips (all brands) — 204 strips / discs per month; glucose test strips combo — 200 strips per month.

    Per-drug quantity limit entries

    Per-drug dispensing limits (examples shown; document contains many additional entries across chunks 72–91).

    Kynamro — Dispensing Limit Per Month: 4 vials / 28 days.
    Kyzatrex — 100 mg: 60 caps / month; 150 mg & 200 mg: 120 caps / month.
    Lagevrio (molnupiravir) — Dispensing Limit Per Month: 40 caps.
    Lamivudine — 100 mg: 30 tabs / month.
    Leucovorin — 5 mg: 120 tabs / month; other strengths with corresponding limits as listed.
    Lidex (fluocinonide) — Dispensing Limit Per Month: 120 grams (cream/gel/ointment) or 120 mL (solution).

    Dispensing quantity limits (selected entries)

    Per-drug dispensing limits (examples from excerpt):

    Naloxone (0.4 mg/ml 10 mL vial) — Dispensing Limit Per Month: 1 vial.
    Narcan (naloxone) nasal spray (4 mg/0.1 mL) — Dispensing Limit Per Month: 4 bottles.
    Naratriptan — Dispensing Limit Per Month: 18 tabs.
    Neulasta — Dispensing Limit Per Month: 2 syringes / 28 days.
    Nexavar (sorafenib) — Dispensing Limit Per Month: 120 tabs.
    Nexium (esomeprazole) — Dispensing Limit Per Month: 60 caps; granules: 60 packets.

    Per-product dispensing limits (excerpt)

    Per-product dispensing limits are specified; where noted, limits apply per month or per specified period.

    Ponvory — Dispensing Limit Per Month: 30 tabs (20 mg default).
    Pradaxa — examples: 110 mg: 120 caps / month; 75 mg & 150 mg: 60 caps / month; packet forms have specified packet limits.
    Prevnar 20 — Dispensing Limit Per Period: 1 vaccine / 90 days.
    ProAir Respiclick / Proventil HFA — Dispensing Limit Per Month: typically 1–2 inhalers (examples show 2 inhalers).

    Dispensing quantity criteria (excerpt)

    Per-product dispensing quantity limits listed; some limits are per month, per 28 days, per 56 days, per 84 days, per 365 days, per lifetime, or other specified period.

    Scemblix — Dispensing Limit Per Month: 120 tabs (strength specified in document).
    Seebri Neohaler — Dispensing Limit Per Month: 60 caps.
    Selzentry (maraviroc) — Dispensing Limits: 150 mg: 60 tabs; 300 mg: 120 tabs; liquid 20 mg/mL: 1840 mL.
    Shingrix — Dispensing Limit / Lifetime: 2 vaccines per lifetime (Dispensing Limit Per Period: 1 vaccine / 90 days noted for other vaccines).
    Skyrizi — examples: 150 mg/mL: 1 pen/syringe/kit per 84 days or 1 cartridge per 56 days (limits vary by presentation).

    Per-drug dispensing limits (excerpt)

    Per-drug dispensing limits (default monthly or specified period) listed; each entry gives drug name, strength (where listed) and Dispensing Limit Per Month unless otherwise noted.

    Tiglutik — Dispensing Limit Per Month: 600 mL.
    Tivicay — Dispensing Limit Per Month: 60 tabs (50 mg default); Tivicay PD: 360 tabs.
    Trikafta — Dispensing Limit Per Month: 90 tabs (tablets); granules: 56 packets / 28 days for oral granules form.
    Tremfya — Dispensing Limit examples: 1 pen or prefilled syringe / 28 days (200 mg/2 mL) or 1 syringe / 56 days (100 mg/1 mL) depending on strength/presentation; Crohn's pack: 3 packs / 180 days.
    Vancocin (vancomycin) — liquid: 1200 mL per month; capsules: 480 caps or 240 caps depending on strength entry; other vancomycin strengths and limits listed.

    Coding / Examples of Limits

    drug dispensing limits listedmixedCovered
    Per-drug dispensing limits (e.g., abacavir = 60 tabs/month; Abilify (aripiprazole) = 30 tabs/month; Abilify Discmelt (aripiprazole ODT) = 60 tabs/month; Actemra = 4 syringes or autoinjectors/28 days)
    sample drug dispensing limitsmixed
    Example entries: Brixadi = 4 syringes/28 days; Brukinsa = 120 caps/month or 60 tabs/month; Buphenyl (sodium phenylbutyrate) = 1200 tabs/month
    drug quantity limitsmixed
    Per-product dispensing limit entries (drug name, strength/form, dispensing limit per month or specified period)
    per-drug quantity limits (partial list)mixed
    Per-drug dispensing limits (examples: Kynamro = 4 vials/28 days; Kyzatrex = 60 caps/month (100 mg) or 120 caps/month (150/200 mg); Lagevrio (molnupiravir) = 40 caps/month; lamivudine 100 mg = 30 tabs/month)
    drug quantity limits (sample)mixed
    Per-drug dispensing limits (examples: Ponvory = 30 tabs/month; Pradaxa = 120 caps or 60 caps depending on strength; Pretomanid = 182 tabs/365 days; Prevnar 20 = 1 vaccine/90 days)
    drug quantity limits (S–T section)mixed
    Multiple drugs with strength and dispensing limit examples (e.g., Scemblix = 120 tabs/month; Seebri Neohaler = 60 caps/month; Selzentry = 60 or 120 tabs/month or 1840 mL; Shingrix = 2 vaccines/lifetime)
    example strengths from segmentmixed
    50 mg/5 mL (vancomycin)Strength listed for vancomycin oral liquid
    125 mg, 250 mg (Vancocin)Capsule strengths listed for Vancocin (vancomycin)
    drug list (W–Z)mixed
    This document lists drugs in the W–Z range and their dispensing limits (examples: Wezlana = 1 syringe/56 days; Xalatan = 2.5 mL; Xalkori = 60–180 caps depending on formulation; Xarelto = 30/60/51 tabs depending on strength or starter pack)
    Afrezza — high-volume dispensing limits (by strength)
    Afrezza (4 unit)2520 cartridges per month
    Afrezza (8 unit)1260 cartridges per month
    Afrezza (12 unit)900 cartridges per month
    Afrezza mix pack (various counts)examples: 1800, 1260, 1080 cartridges per month depending on pack
    Diabetic test strips — monthly limit
    Glucose/Diabetic test strips (all brands)204 strips/discs per month
    Glucose test strips combo200 strips per month
    Freestyle Libre 2 (reader)referenced under readers; other limits listed on page
    Dexcom / CGM receiver limits
    Dexcom Receiver / Freestyle Libre 2 reader1 receiver (or reader) per 365 days (specified as reader/annual) — see related entries
    Insulin pump/kit entriesother device limits shown elsewhere in list (per specified periods)
    Refer to device-specific linelimits vary by product and are listed in the per-product section
    Typical dispensing limit units / periods
    Typical dispensing limit unitper month (default) — or per specified period such as per 28 days, 30 days, 84 days, 180 days, or 365 days
    Examples of alternate periods28 days, 30 days, 56 days, 84 days, 180 days, 365 days
    Notation'Dispensing Limit Per Month unless otherwise noted' indicates month is the default period
    Example dispensing limits — selected products
    Glatopa 20 mg (glatiramer acetate)30 syringes per month
    Glatopa 40 mg (glatiramer acetate)12 syringes per 28 days
    Glucose Test Strips (all brands)204 strips/discs per month
    Per-day / per-month topical and patch limits (examples)
    Lidocaine/prilocaine cream 2.5%/2.5%2 grams per day
    Lidocaine topical ointment 5%3.3334 grams per day
    Lidoderm (lidocaine patch) 5%3 patches per day
    Naloxone dispensing limits — vial and nasal spray
    Naloxone (0.4 mg/mL, 10 mL vial)1 vial per month
    Narcan (naloxone) nasal spray (4 mg/0.1 mL)4 bottles per month
    Dispensing limit examples — common product types
    Typical tablet/capsule examples30 tabs/month; 60 caps/month; 182 tabs/365 days
    Inhaler example2 inhalers per month (example entry) or per specified 28 days
    Vaccine example1 vaccine per 90 days
    Other formsperiods vary by product (see per-product entries)
    Dispensing limits — per-drug numeric examples
    Per-drug numeric limitsEach drug line specifies a numeric limit expressed as number of units per month or other period (examples vary by product)
    Volume examplesXalatan 2.5 mL; Xarelto 30 tabs/60 tabs; Xolair 2–8 syringes/28 days
    Refer to full listMany additional product-specific limits are listed alphabetically; consult the entry for each strength/form
    Tiglutik dispensing limit
    Tiglutik (oral solution)600 mL per month
    Tivicay dispensing limit
    Tivicay (dolutegravir) — 50 mg60 tablets per month (50 mg strength default)
    Trikafta dispensing limit (tablets)
    Trikafta (tablets)90 tablets per month
    Vascepa dispensing limits by strength
    Vascepa (0.5 g strength)240 capsules per month
    Vascepa (1 g strength)120 capsules per month
    Per-drug numeric limits — selected W–Z examples
    Xalatan (latanoprost)2.5 mL per dispensing period
    Xarelto (rivaroxaban)Starter pack 51 tabs; typical strengths 30 tabs or 60 tabs depending on strength
    Xolair (omalizumab)2–8 syringes per 28 days depending on strength/indication

    Authorization and Override Process

    Documentation Required

    Use Quantity Limit Authorization Form for exceptions

    Quantity Limit Authorization Form is referenced for requesting exceptions to listed quantity limits.

    Prior Authorization

    Quantity Limit Authorization Form available online

    The Quantity Limit Authorization Form is available at the provided URL; Responsible Quantity program limits apply to generic versions of drugs where applicable.

    • Form URL: http://www.bcbsfl.com/DocumentLibrary/Providers/Content/RxF_QuantityLimit.pdf
    • Program limits apply to generic versions where applicable.
    Note

    Responsible Quantity limits apply to generics; use form for exceptions

    Responsible Quantity program limits apply to generic versions of drugs where applicable; refer to the Quantity Limit Authorization Form for exceptions or overrides.

    • Limits are not limited to brand products and apply to generics where available.
    • Use the Quantity Limit Authorization Form to request exceptions.
    Prior Authorization

    Reference Quantity Limit Authorization Form for requests

    The Quantity Limit Authorization Form is referenced as the mechanism to request quantity limit approvals or overrides.

    Prior Authorization

    Submit requests via Quantity Limit Authorization Form

    Providers must use the Quantity Limit Authorization Form when requesting authorization for quantities beyond the listed limits.

    Prior Authorization

    Quantity limit exception requests require the Form

    The policy repeatedly references the Quantity Limit Authorization Form as the process for requesting exceptions to responsible quantity limits.

    Prior Authorization

    Use the Authorization Form to request overrides

    For any request to exceed the Responsible Quantity Program limits, submit the Quantity Limit Authorization Form as specified in the policy.

    Prior Authorization

    External Quantity Limit Authorization Form for overrides

    The Quantity Limit Authorization Form is provided via external URL for requesting overrides or authorizations to quantity limits.

    • Form URL provided in document for submission of requests.
    Documentation Required

    Quantity Limit Authorization Form available at URL

    The Quantity Limit Authorization Form is available at the document’s provided URL for submitting quantity-limit authorization requests.

    • Refer to the linked form at http://www.bcbsfl.com/DocumentLibrary/Providers/Content/RxF_QuantityLimit.pdf
    Documentation Required

    Reference the Authorization Form for exceedance requests

    The Quantity Limit Authorization Form is referenced for authorization requests to exceed listed dispensing limits.

    Documentation Required

    Quantity Limit Authorization Form (link)

    Quantity Limit Authorization Form is available at http://www.bcbsfl.com/DocumentLibrary/Providers/Content/RxF_QuantityLimit.pdf for submitting requests to exceed quantity limits.

    Prior Authorization

    Form referenced; generics are subject to limits

    The Quantity Limit Authorization Form is referenced on policy pages (link provided); Responsible Quantity program limits apply to generic versions of drugs where applicable.

    • Form link included in policy pages.
    • Program limits apply to generics where available.
    Prior Authorization

    Repeat: submit form for exceptions (generics apply)

    The Quantity Limit Authorization Form is reiterated on current-dated pages; use it to request exceptions to the Responsible Quantity Program limits that may apply to generic versions.

    Prior Authorization

    Submit Quantity Limit Authorization Form for exceptions

    The Quantity Limit Authorization Form is available at the provided URL for requesting exceptions or authorizations to quantity limits under the Responsible Quantity Program.

    • Form URL: http://www.bcbsfl.com/DocumentLibrary/Providers/Content/RxF_QuantityLimit.pdf
    • Used to request exceptions/authorizations to quantity limits.

    Key Terms and Scope

    Responsible Quantity Program — definition and notes
    Responsible Quantity ProgramA program that sets dispensing quantity limits for listed drugs; limits apply to generic versions where applicable and are enforced per specified time periods
    Quantity Limit Authorization FormExternal form referenced for requesting exceptions or authorizations (URL provided in document)
    Application to genericsProgram limits apply to generic versions where applicable (limits not limited to brand products only)
    Quantity Limit Authorization Form — reference
    Quantity Limit Authorization Form (form)Quantity Limit Authorization Form available at http://www.bcbsfl.com/DocumentLibrary/Providers/Content/RxF_QuantityLimit.pdf
    UseForm is referenced repeatedly as the process for requesting overrides or quantity exceptions
    AvailabilityLinked on multiple pages of the Responsible Quantity Program document
    Responsible Quantity Program — application to generics
    Generics applicabilityResponsible Quantity program limits may apply to generic versions of drugs where applicable
    ImplicationLimits are not restricted to brand products; generic equivalents are subject to the same dispensing caps where listed
    ReferenceStatement appears repeatedly across the document pages
    Dispensing Limit Per Month — definition
    Dispensing Limit Per Month (definition)The maximum quantity of the listed product that may be dispensed in the stated period unless otherwise noted
    Default periodPer month is the default unless an alternate period (e.g., 28 days, 84 days, 365 days) is specified
    EnforcementLimits govern dispensing for covered outpatient prescriptions under the Responsible Quantity Program
    Responsible Quantity Program — scope & access
    Responsible Quantity Program overviewA program that sets monthly dispensing quantity limits for prescription drugs; limits apply to generic versions where applicable and an authorization form is provided for exceptions
    Authorization form linkhttp://www.bcbsfl.com/DocumentLibrary/Providers/Content/RxF_QuantityLimit.pdf
    Document effective dateCurrent 7/1/2026 (appears on multiple pages)
    Policy Summary
    PayerFlorida Blue
    PolicyResponsible Quantity Program — Drug Dispensing Quantity Limits
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJul 1, 2026
    Next Review DateN/A
    Key ActionUse the Quantity Limit Authorization Form (linked) to request exceptions or overrides to listed dispensing limits.
    SourceLink
    On This Page
    Drug Dispensing Quantity LimitsCoding / Examples of LimitsAuthorization and Override ProcessKey Terms and Scope
    Epivir (lamivudine) — multiple strengths; Dispensing Limits shown (examples: 960 mL, 60 tabs, 30 tabs).
    Glatopa (glatiramer acetate) — 20 mg: 30 syringes / month; 40 mg: 12 syringes / 28 days.
    Gleevec (imatinib) 100 mg — Dispensing Limit Per Month: 90 tabs (400 mg example: 60 tabs).
    Glucose Test Strips (all brands) — Dispensing Limit Per Month: 204 strips / discs (combo example: 200 strips).
    Lidoderm (lidocaine patch) — Dispensing Limit: 3 patches per day.
    Lipitor (atorvastatin) — examples: 10–40 mg: 45 tabs / month; 80 mg: 30 tabs / month.
    Lyrica (pregabalin) — Dispensing limits vary by strength (examples listed: 360 caps, 270 caps, 180 caps, 90 caps, 60 caps).
    Mavenclad (cladribine) — tab-pack specific limits: examples show limits over 301 days (e.g., 8 tabs up to 20 tabs / 301 days).
    Norco (hydrocodone-acetaminophen) 5 mg/325 mg — Dispensing Limit Per Month: 360 tabs (other strengths with lower monthly limits as listed).
    Omnipod (various packs) — Dispensing Limit Per Month: 30 pods; certain kits limited to 1 kit per 720 days or 1 kit per 720 days as specified.
    Ozempic — Dispensing Limit Per Month: 1 pen / 28 days (example shown elsewhere in list).
    Vascepa (icosapent) — 0.5 g: 240 caps / month; 1 g: 120 caps / month.
    Venclexta — Dispensing Limits vary by strength (examples: 60 tabs, 30 tabs, 120 tabs; starter pack 1 pack / 180 days).
    Wezlana — Dispensing Limit examples: 45 mg/0.5 mL: 1 syringe or vial / 84 days; 90 mg/1 mL: 1 syringe / 56 days (document shows both entries).

    Note

    • This segment (W–Z) contains many additional drug-specific limits across strengths and specified periods; refer to the full list for product- and strength-specific dispensing limits.